BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15866044)

  • 1. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
    Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
    Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
    J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
    Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
    Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice.
    Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B
    Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S; Strittmatter SM
    J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
    Cafferty WB; Duffy P; Huebner E; Strittmatter SM
    J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-siNgR199 promotes axonal regeneration and functional recovery in rats.
    Lv B; Yuan W; Xu S; Zhang T; Liu B
    Int J Neurosci; 2012 Mar; 122(3):133-9. PubMed ID: 22023338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
    Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
    Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
    Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Jisuikang on Nogo-NgR gene expression in spinal cord rats with injury].
    You WL; Zhang YF; Chen JF; Yin H; Yang JF; Wang JW
    Zhongguo Gu Shang; 2015 Mar; 28(3):235-9. PubMed ID: 25936193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice.
    Geoffroy CG; Lorenzana AO; Kwan JP; Lin K; Ghassemi O; Ma A; Xu N; Creger D; Liu K; He Z; Zheng B
    J Neurosci; 2015 Apr; 35(16):6413-28. PubMed ID: 25904793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?
    Teng FY; Tang BL
    J Neurochem; 2005 Aug; 94(4):865-74. PubMed ID: 16092935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NgR acts as an inhibitor to axonal regeneration in adults.
    Zhang S; Zhang Q; Zhang JH; Qin X
    Front Biosci; 2008 Jan; 13():2030-40. PubMed ID: 17981689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.